AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
167 hedge funds and large institutions have $1.09B invested in Aerie Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 77 increasing their positions, 31 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $1.43B → $1.09B (-$339M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
167
Holding in Top 10
5
Calls
$16.9M
Puts
$7.68M
Top Buyers
| 1 | +$35.2M | |
| 2 | +$29.5M | |
| 3 | +$27.2M | |
| 4 |
LCS
Levin Capital Strategies
New York
|
+$18.6M |
| 5 |
KCM
Kingdon Capital Management
New York
|
+$15.6M |
Top Sellers
| 1 | -$44.5M | |
| 2 | -$27.5M | |
| 3 | -$25.2M | |
| 4 |
Neuberger Berman Group
New York
|
-$16.3M |
| 5 |
Jennison Associates
New York
|
-$14.8M |